-
0days
-
0Hours
-
0Minutes
Arrival, check-in, exhibition touring, and networking.
The Asia Pacific MedTech Forum 2026 will open with welcome remarks from APACMed leadership and the government of Singapore. This session will set the stage for two days of discussions on how medical technologies can drive innovation, strengthen healthcare systems, and deliver measurable impact across the Asia Pacific region. APACMed leadership will reflect on the role of the MedTech industry in advancing regional collaboration and healthcare transformation. The government will then share Singapore’s perspective on fostering innovation, strengthening the healthcare ecosystem, and supporting the growth of the MedTech sector.
Innovation remains the lifeblood of the MedTech industry, yet the journey from breakthrough technology to widespread adoption is often complex and uncertain. In this keynote, a global industry leader will reflect on lessons learned from building and scaling a successful MedTech company, including the factors that enable sustained innovation, growth, and impact. The session will explore how emerging technologies such as AI are reshaping the future of healthcare and what industry leaders, policymakers, and innovators should consider as they seek to translate innovation into better patient outcomes. Attendees will gain perspectives relevant to organizations at every stage of growth, from emerging innovators to established global enterprises.
MedTech innovation is accelerating across multiple fronts — from AI-enabled diagnostics and surgical robotics to connected devices and preventive health solutions. At the same time, new models of frugal and reverse innovation are emerging from Asia and other fast-growing markets. This executive panel will explore where the next wave of MedTech innovation is heading and what innovations are most likely to reshape healthcare delivery across Asia Pacific over the coming decade.
Exhibition touring, networking, and possibly remarks from sponsors.
Healthcare delivery is evolving rapidly as new care models emerge to address workforce constraints, rising demand, and shifting patient expectations. Innovations such as virtual care, hospital-at-home, digitally enabled chronic disease management, and AI-supported clinical workflows are beginning to reshape how care is delivered across health systems. This fireside conversation will explore how these models are moving from concept to real-world implementation, what enables successful adoption, and how MedTech companies can work with providers, governments, and technology partners to scale these approaches across the Asia Pacific region.
Wrap-up, BBC series launch (with John Collings, Stryker APAC President), and any instructions.
Lunch, exhibition touring, and networking.
Despite rapid innovation across AI, robotics, and connected devices, many promising healthcare solutions remain trapped in pilots and isolated implementations. This keynote will explore what it takes to move beyond experimentation and achieve population-scale integration across health systems by 2030.Drawing on global trends in healthcare innovation, system design, and futures thinking, the session will examine how organizations can modernize care delivery, integrate emerging technologies responsibly, and prepare for the next era of healthcare. The keynote will build on the strategic context of the Forum by outlining the opportunities and system-level shifts required to translate MedTech innovation into meaningful health outcomes across Asia Pacific.
Significant progress has been made across Asia Pacific in building the digital foundations of modern healthcare systems. Yet important gaps remain in interoperability, data governance, cybersecurity, and the integration of new technologies such as AI into clinical environments. This panel will examine how health systems, industry, and policymakers can work together to strengthen digital infrastructure required to support next-generation healthcare delivery. The discussion will explore practical lessons from recent initiatives (in Asia Pacific and globally) and identify priorities for achieving secure, interoperable, and scalable digital health ecosystems across the region.
Singapore and Asia Pacific play a critical role in the global MedTech innovation ecosystem, with multinational companies expanding R&D activities across the region to access talent, diverse patient populations, manufacturing capabilities, and fast-growing healthcare markets. This fireside chat will explore how global MedTech companies are structuring and integrating R&D programs across Asia Pacific, including partnerships with healthcare providers, academia, governments, and innovation hubs. The discussion will highlight key trends, successful models, and lessons learned, while also addressing ongoing challenges related to regulation, talent, data access, and cross-border collaboration. The session will examine how stronger integration between regional ecosystems and global innovation networks can accelerate the development and adoption of next-generation medical technologies.
Exhibition touring, networking, and possibly remarks from sponsors.
Innovative startups are increasingly contributing to the future of healthcare across Asia Pacific. This session will feature a curated group of MedTech startups presenting solutions aimed at addressing major healthcare challenges across the region, including workforce constraints, chronic disease management, diagnostics, and access to care. The showcase will emphasize the importance of partnerships, ecosystem integration, and scalable business models in translating innovation into real-world adoption. Industry leaders and ecosystem stakeholders will provide perspectives on what it takes for emerging companies to successfully scale within complex healthcare environments.
Day 1 will conclude with a brief reflection on the key themes, insights, and areas of debate that emerged throughout the Forum's discussions on innovation and integration.
Informal flow with audience and sponsors.
This closed-door roundtable will explore how private equity investors identify opportunities, create value, and support the scaling of high-potential MedTech businesses. Drawing on perspectives from investors and industry leaders, the discussion will examine key market trends, investment priorities, and the characteristics that distinguish successful mid-market MedTech companies. The session will provide a candid view of where capital is flowing and what it will take to build the next generation of regional and global MedTech leaders.
Arrival, check-in, exhibition touring, and networking.
Day 2 will open with perspectives from APACMed's leadership on the evolving role of the medical technology industry in advancing healthcare capacity and capability across Asia Pacific. This session will outline the organization's strategic priorities for the coming years and highlight how APACMed aims to strengthen collaboration between industry, policymakers, and healthcare providers.It will also reflect on key insights from Day 1 and connect them to the broader mission of accelerating innovation, integration, and impact across the region. The discussion will provide a forward-looking perspective on how APACMed will continue to support the MedTech ecosystem and advance healthcare outcomes and talent across Asia Pacific.
As healthcare systems adopt increasingly sophisticated medical technologies, the challenge is no longer innovation alone, but how to demonstrate that these solutions are impactful in real-world clinical environments. This keynote will outline a practical playbook for translating MedTech innovation into scalable healthcare delivery, addressing the infrastructure, partnerships, and policy frameworks required for successful implementation. It will also explore how global supply chains, regulatory environments, and geopolitical dynamics (such as tariffs and localization) are shaping how technologies are developed, manufactured, and deployed across regions. The session will highlight lessons for industry leaders seeking to build resilient, integrated healthcare ecosystems across Asia Pacific.
While MedTech innovation is advancing rapidly, translating this innovation into patient access increasingly depends on the alignment of policy, regulatory, compliance, and reimbursement frameworks. This session brings together policymakers, industry, and healthcare leaders to explore how more agile approaches and value-based reimbursement models can accelerate access to innovation. The discussion will focus on practical strategies to enable scalable safe adoption while balancing cost, sustainability, and patient outcomes.
Exhibition touring, networking, and possibly remarks from sponsors.
Reflecting on two days' worth of conversations, MedTech leaders are being challenged to rethink how innovation, partnerships, and technology can create lasting value for patients and providers. This fireside conversation will explore the trends expected to shape the industry over the coming years, from AI and digital health to new care models and changing market dynamics. Looking beyond today's priorities, the discussion will offer a forward-looking perspective on where the greatest opportunities and risks may emerge, and how industry stakeholders can work together to strengthen healthcare across Asia Pacific.
Wrap-up remarks for the overall Forum, and instructions for expert tracks.
Lunch, exhibition touring, and networking.
This expert track will bring together government, industry, and healthcare providers to explore how circular economy principles can be practically applied in MedTech. The discussion will cover policy direction, industry innovations in ecodesign, and real-world challenges in implementation, including safety and regulatory constraints. Perspectives from hospitals and labs will highlight demand-side expectations and operational realities. The session will also draw on regional examples to identify scalable and collaborative approaches to advancing sustainability in healthcare.
This expert track will bring together cybersecurity experts, regulators (MedTech and cyber), industry and healthcare providers to discuss how to maintain cyber resilience (secure-by-design medical devices). Of particular importance as we operate in an increasingly connected, cloud enabled and AI-driven healthcare ecosystem while adopting harmonised and risk-based cybersecurity regulations to support medical device innovation in Asia Pacific.
Arrival, check-in, exhibition touring, and networking.
Across Asia Pacific, the hardest gap to cross is not invention — it is the leap from a successful pilot to standard practice inside a hospital, payer, or ministry system. This two-hour Startup-Stage session confronts the "messy middle" of adoption: clinical validation, procurement and tender pathways, reimbursement, data interoperability, and the change management required for clinicians and administrators to embrace new tools.Through a mix of short startup showcases and a moderated cross-sector panel — bringing together founders, hospital and health-system leaders, payers and regulators — the session surfaces what actually moves an innovation from a single department to a regional protocol, and where partners can de-risk that journey.
- 10:00–10:10 Framing: the pilot-to-protocol gap in Asia Pacific
- 10:10–11:00 Startup showcase — 5–6 ventures on integration into real workflows
- 11:00–11:50 Panel — providers, payers, a regulator and a scaled founder on adoption pathways
- 11:50–12:00 Audience Q&A and key takeaways
Lunch, exhibition touring, and networking.
Capital is the oxygen of scale — yet MedTech founders in Asia Pacific face a fragmented financing landscape spanning grants, venture, corporate venture, strategic partnerships, and M&A. This two-hour session follows the money: how investors and corporates actually evaluate MedTech ventures, what makes a company "scale-ready," and how partnerships and follow-on capital bridge the journey from regulatory approval to commercial traction across multiple markets.Combining investor-led insight, a corporate–startup partnership panel and live founder pitches, it closes the loop on the day — turning the innovation and integration conversations into a concrete map of who funds what, and how impact gets measured and sustained.
- 14:00–14:10 Framing: the Asia Pacific MedTech capital landscape
- 14:10–14:55 Panel — VC, corporate venture and a scaled founder on funding the scale-up bridge
- 14:55–15:40 AMPLIFY pitch session — finalists pitch to the panel / judges
- 15:40–15:50 Awards moment and close
Arrival, check-in, exhibition touring, and networking.
Program details to be defined by secured partner. This session involves Plug & Play (with IHH) or the MedTech Actuator program, also involving banks, funds, and other member companies.
Lunch, exhibition touring, and networking.
China is playing an increasingly prominent role in shaping the future of MedTech through advances in research, technology development, digital health, diagnostics, and artificial intelligence. This expert track will explore how Chinese and international stakeholders are working together to advance innovation, strengthen healthcare ecosystems, and address shared healthcare challenges.Speakers will discuss emerging trends, collaboration models, and opportunities for cross-border partnerships that can accelerate the development and adoption of innovative healthcare solutions. The discussion will provide a forward-looking perspective on China's evolving contribution to the broader Asia Pacific and global MedTech landscape.
Building on discussions from the MedTech Forum 2025 in India, this session will explore how the country's healthcare and MedTech sectors are being reshaped by a unique convergence of economic growth, healthcare reform, investment, insurance expansion, and technological innovation.As MedTech becomes an increasingly important pillar of India's healthcare strategy, stakeholders across the ecosystem have an opportunity to align around shared priorities and accelerate the next phase of growth. The discussion will examine emerging partnership models, evolving healthcare delivery dynamics, and the opportunities created when industry, providers, payors, investors, and policymakers work together to advance a more innovative, accessible, and patient-centric healthcare system.